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The ionization of phosphorylated peptides is usually suppressed by non-phosphorylated
peptides when -cyano-4-hydroxycinnamic acid (CHCA) is used as a matrix for matrix-
assisted laser desorption/ionization-time-of-Flight (MALDI-TOF) mass spectrometry analysis.
In the present study, we examined the effect of diammonium citrate addition to the CHCA
matrix on the detection of phosphorylated peptides. Substrates for protein kinase C (PKC) and
c-Src were synthesized and phosphorylated by reaction with cell and tissue lysate samples.
The addition of diammonium citrate to the CHCA matrix increased the sensitivity for
distinguishing phosphorylated peptides from background noise. However, the effect de-
pended on substrate concentration. (J Am Soc Mass Spectrom 2007, 18, 1925–1931) © 2007
American Society for Mass SpectrometryProtein phosphorylation is one of the most impor-tant post-translational modifications, as it regu-lates cellular functions through information pro-
cessing [1–3]. In this context, the determination of
phosphorylated peptides using mass spectrometry has
attracted much attention in many biological and phar-
macological fields. The detection limit for phosphory-
lated peptides in mass analysis is dependent on several
factors such as ionization efficiency, mass, and hydro-
phobicity. Matrix-assisted laser desorption/ionization
(MALDI) is relatively tolerant of salts and buffer com-
ponents such as sodium chloride and phosphate, par-
ticularly when compared with most other forms of mass
spectrometric ionization. However, when the concen-
tration of these components is high, crystal formation
may be prevented and ionization impeded [4, 5]. More-
over, cell lysates contain many biomolecules such as
proteins and lipids, and relatively high concentrations
of contaminants including buffers. These components
can also prevent crystal formation and interfere with
ionization.
For example, previous studies suggested that the
ionization of phosphorylated peptides is usually sup-
pressed by unphosphorylated peptides when -cyano-
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[6–10]. Several attempts have been made to reduce this
effect [6–10]. Among them, the addition of diammo-
nium citrate to the CHCA matrix can increase the peak
intensity of the phosphorylated peptides or proteins [6,
10]. This may be a simple and useful method to identify
the phosphorylated peptide or protein for certain pro-
tein kinases. However, there is very little data concern-
ing the application of diammonium citrate in matrices
for the detection of phosphorylated peptides from cell
and tissue samples.
In the present study, two substrates for protein
kinase C (PKC) and c-Src were used to test and
optimize the effectiveness of diammonium citrate to
enhance our ability to detect phosphorylated peptides
from cell and tissue samples. PKC, a calcium- and
phospholipid-dependent serine/threonine kinase con-
sisting of 11 isozymes [11–13], appears to be involved in
the signal transduction response to a variety of hor-
mones and growth factors. Certain isozymes such as
PKC, are considered to play an important role in
carcinogenesis and tumor growth [14].
c-Src is a non-receptor tyrosine kinase that is known
to increase in a multitude of human tumors, including
breast, stomach, colon, and prostate. Activated c-Src can
phosphorylate the human epidermal growth factor re-
ceptor (HER), which is the prototype of a family that
consists of four members (epidermal growth factor
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erbB4/HER4), leading to tumor cell growth and prolif-
eration [3, 15–17].
Thus, the phosphorylation of serine, threonine, and
tyrosine residues by such protein kinases has an impor-
tant influence on diverse biological phenomena, includ-
ing signal transduction, cell division and motility, apo-
ptosis, and carcinogenesis [3, 11–19].
Experimental
Peptide Synthesis
Substrates for PKC (FKKQGSFAKKK; MW, 1336.8)
and c-Src (CXXEEIYGEFD, where X connotes the group
[-NH(CH2CH2O)2CH2CO-]; MW, 1392.5) were synthe-
sized using an automatic peptide synthesizer according
to standard Fmoc-chemistry. The latter peptide can be
fixed to the slide glass for application as a peptide array.
The Cys residue and linkages are known to have no
effect on the phosphorylation of the substrate [20, 21].
After trifluoroacetic acid (TFA) cleavage, the peptide
was purified on an Inertsil ODS-3 column (250  20
mm, 3.5 m, GL Sciences Inc., Tokyo, Japan) using a
BioCAD perfusion chromatography system (Ikemoto
Scientific Technology Co., Tokyo, Japan) under a linear
A-B gradient at a flow rate of 8 mL/min, where eluent
A was 0.1% TFA in water and eluent B was 0.1% TFA in
acetonitrile (HPLC grade).
Sample Preparation for MALDI Time-of-Flight
(TOF) Mass Spectrometry
The -cyano-4-hydroxycinnamic acid (CHCA) matrix
(10 mg/mL) was prepared in 50% water/acetonitrile
and 0.1% TFA. The modified CHCA matrix included
diammonium citrate (5 mg/mL). The matrix and sam-
ple were mixed in ratios of 1:1, 2:1, 3:1, 4:1, and 5:1. A
total volume of 1 L of the analyte/matrix mixture was
applied on the sample plate and allowed to dry to
induce crystallization.
MALDI-TOF Mass Spectrometry
Experiments were conducted using a Voyager DE RP
BioSpectrometry Workstation (Applied Biosystems,
Framingham, MA) in positive or negative ion reflectron
mode. The accelerating voltage was 20 kV with a 100-ns
extraction delay time. Typically, 100 laser shots were
averaged to improve the signal-to-noise ratio. All spec-
tra were analyzed using Data Explore software (Ap-
plied Biosystems). Triplicate samples were prepared
and each was analyzed twice. Means of the phosphor-
ylation ratio obtained from three spots selected manu-
ally on the crystals were used as results for assay
purposes. The phosphorylation ratio is defined as the
ratio of ion intensities for the phosphorylated to un-
phosphorylated material, and this was calculated as
described previously [22] .Phosphorylation of Substrates with PKC
and c-Src Enzyme
Phosphorylation of the PKC substrate was carried out
in 10 L of buffer [20 mM Tris-HCl at pH 7.5, 10 mM
MgCl2, 0.5 mM CaCl2, 100 M adenosine triphosphate
(ATP), 2 g/mL diacylglycerol (DAG), and 2 g/mL
phosphatidylserine (PS)] containing 30 M synthetic
peptide and 0.1 g/mL of PKC.
For c-Src, 10 L of buffer (20 mM Tris-HCl at pH 7.5,
10 mM MgCl2, and 100 M ATP) containing 30 M
synthetic peptide and 0.1 g/mL of c-Src. After incu-
bation for 60 min at 37 °C, the sample was analyzed by
MALDI-TOF mass spectrometry.
Cell Culture and Lysate Preparation
B16 melanoma cells were maintained in Dulbecco’s
modified Eagle’s medium supplemented with 10% fetal
bovine serum, penicillin (100 U/mL), streptomycin (100
g/mL), and amphotericin B (0.25 g/mL). The cells
were kept in a humidified atmosphere containing 5%
CO2 and 95% air at 37 °C. The cultured cell was then
scraped and lysed in 20 mM Tris-HCl buffer (pH 7.5) by
sonication. The sample was centrifuged at 5000  g for
60 min at 4 °C. The supernatant (200 g/mL) was used
as a whole cell lysate (membrane and cytosol fractions)
for the phosphorylation reaction.
For the detection of total protein concentration, stan-
dard working bovine serum albumin (BSA) solutions of
0.125 to 2 mg/mL were prepared by diluting aliquots of
the stock solution (10 mg/mL) in water. A 10-L
volume of the standard BSA solution was mixed with 1
mL of Bio-Rad Protein assay Dye reagent (BIO-RAD
Lab., Hercules, CA) and detected by the absorbance at
595 nm. Calibration curves for concentrations (0.125 to 2
mg/ml) versus detector responses (absorbance at 595
nm) were obtained using a linear regression program.
The correlation coefficients of absorbance to concentra-
tion were 0.998. A 10-L volume of cell extract was
mixed with 1 ml of Bio-Rad protein assay dye reagent.
The protein concentration was detected using a UV
system, and calculated from the corresponding calibra-
tion curve.
Tissue Lysate Preparation
In the present study, all animal studies were performed
in accordance with the Guidelines for Animal Experi-
ments, set out by the Kyushu University.
Male 5-wk old BALB/c mice, weighing 20 g, were
used in this study. The dorsal side was inoculated
subcutaneously with 1  106 B16 melanoma cells per
100 L of Hanks’ balanced salt solution (Gibco) per
animal. Tumors were allowed to grow to a mean
diameter of 0.7 to 1.0 cm.
Tissue lysates for PKC were obtained from excised
tumors grown in mice. After the tumors were weighed,
they were homogenized in 10 mL of buffer [20 mM
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itor (Roche, Tokyo, Japan)]. The homogenate was cen-
trifuged at 1000  g at 4 °C for 10 min and the
supernatant was removed. After washing the precipi-
tate with 5 mL of buffer and re-centrifuging, 1 mL of
buffer was added and the precipitate further sonicated
for 30 s. After sonication of the homogenate, the sam-
ples were centrifuged at 5000 g at 4 °C for 15 min, and
the resulting supernatant (200 g/mL) was used as a
whole lysate sample for the phosphorylation reactions.
Total protein concentration was detected with the aid of
a Bio-Rad protein assay dye reagent. The lysate of
normal skin tissue was also prepared according to the
same method.
For c-Src, brain tissue was homogenized in 10 mL
of buffer [20 mM Tris-HCl, pH 7.5, 250 mM sucrose,
and protease inhibitor (Roche)]. The homogenate was
centrifuged at 100,000  g at 4 °C for 60 min and the
supernatant was removed. After washing the precip-
itate with 5 ml of buffer and re-centrifuging, 1 mL of
buffer with 0.2% Triton X-100 was added and the
precipitate further sonicated for 30 s. After sonication
of the homogenate, the samples were centrifuged at
100,000  g at 4 °C for 30 min, and the supernatant
(200 g/mL) was used for the phosphorylation reac-
tion.
Statistical Analysis
Statistical analysis consisted of significance testing of
the differences between means by Student’s t-test at the
Figure 1. Typical MALDI-TOF mass spectra o
PKC (a) or c-Scr (b) with each target enzym
phosphorylated peptide.following significance levels: P  0.1 and P  0.5.Results and Discussion
Phosphorylation of Two Substrates by Target
Enzyme
In a previous study, we found that the substrate
(FKKQGSFAKKK) showed a higher phosphorylation
ratio on PKC [22]. Here, the same substrate was used
in the phosphorylation reaction for PKC. A substrate
specific to c-Src (EEIYGEFD) was synthesized according
to a study reported by Songyang et al. [23].
Phosphorylation of the two substrates by each target
enzyme was identified by an increase in them/z value of
80 Da (Figure 1) [6–10]. In the case of c-Src, no
phosphorylated peak was observed using positive ion
reflectron mode, which may be a result of the substrate
for c-Src containing four anionic amino acid residues (E
and D). On the other hand, detection using the negative
ion reflectron mode revealed a phosphorylated peak.
Suitable Ratio of Matrix and Sample
In the present study, CHCA was used as a matrix for
analysis. The 1:1 volume ratio of CHCA matrix and
melanoma cell lysate sample prevented crystal forma-
tion and interfered with the ionization. These results
may be caused by known or suspected contaminants
and biomolecules such as Tris base, proteins, and lipids.
Two simple methods for reducing these contaminants
involve washing the samples with 5 to 10 L of either
distilled deionized water or 0.1% TFA. This process also
serves to dilute the samples [4]. Since the former
method can often lead to sample losses, the dilution
ed from phosphorylation of the substrates for
n increase of 80 Da was identified for thebtain
e. Amethod was used in this study. When the ratio of
1928 KANG ET AL. J Am Soc Mass Spectrom 2007, 18, 1925–1931CHCA to sample was increased more than 2-fold (2:1 to
5:1), the tolerance for the contaminants was enhanced
and crystal formation and ionization occurred. A 5:1
ratio of matrix to sample achieved the best invariable
peaks of the phosphorylated peptide from the whole
range of the plate (data not shown). In the present
study, therefore, a 5:1 ratio of matrix to sample was
used for detecting phosphorylated peptides in the cell
and tissue lysates.
Moreover, MALDI-TOF mass spectrometry can be
used to analyze a wide range of peptide concentrations,
from 104 M (100 pmol/L) to 108 M (10 fmol/L) [4].
In the present study, the concentration of peptide (5
M) in the ratio 5:1 is included in this range.
Phosphorylation of PKC Substrate with Cell Lysate
After phosphorylation of the PKC substrate with the
cell lysate of B16 melanoma, no peaks of the phosphor-
ylated peptide were found. These results may be caused
by a loss of indispensable factors for the PKC phos-
phorylation reaction during cell lysate preparation.
PKC consists of a single polypeptide chain with an
amino-terminal regulatory region and a carboxyl-
terminal catalytic region. The regulatory region of
PKC contains an auto-inhibitory domain (pseudo-
substrate) and two membrane-targeting domains (C1
and C2). The C1 domain binds to diacylglycerol (DAG),
while the C2 domain contains many acidic amino acids
that take part in Ca2 binding. The catalytic region
contains two domains (C3 and C4). The C3 domain
Table 1. Change of phosphorylation ratio after the addition of
activator and/or cofactors to the cell reaction lysate
Activator and/or cofactor
Phosphorylation
ratio (%)
(n  3)
Mg2  ATP 28.5  2.1
Mg2  ATP  Ca2 24.8  3.6
Mg2  ATP  PS 27.0  3.6
Mg2  ATP  PS  Ca2 26.2  5.6
Mg2  ATP  DAG 45.5  2.3
Mg2  ATP  DAG  Ca2 46.6  1.1
Mg2  ATP  DAG  PS 47.9  5.0
Mg2  ATP  DAG  PS  Ca2 57.2  4.8
Table 2. Ionization efficiencies of the phosphorylated and non-p
Peptide concentration (M)
Without diammoni
Peptide Phospho
7.5 100 6
15 100 6
30 100 7
60 100 7
120 100 7
240 100 76.8 contains the adenosine triphosphate (ATP)-binding mo-
tif while the C4 domain binds to the substrate. For
substrate phosphorylation by PKC, DAG, Ca2, and
ATP were found to be indispensable factors [11–13, 19].
A phosphatidylserine (PS)-binding domain is not found
in PKC, but PS shows synergistic activation with DAG
and Ca2 during phosphorylation [11–13]. DAG is a
basic component of membranes and serves as hydro-
phobic anchors in PKC and membrane interaction. It is
produced in the hormone-sensitive phosphatidylinosi-
tol system. Active phospholipase C cleaves plasma
membrane lipid phosphatidylinositol-4,5-bisphosphate
into DAG and inositol-1,4,5-trisphosphate [11, 24, 25].
On the other hand, PS is an acidic membrane phospho-
lipid and is produced by the displacement of cytidine
monophosphate through nucleophilic attack by the
hydroxyl group of serine [11, 24, 25].
Therefore, we investigated the indispensable factors
for the PKC phosphorylation reaction. Phosphoryla-
tion did not occur in the absence of Mg2 and ATP. The
addition of only ATP did not lead to substrate phos-
phorylation (data not shown). However, the addition of
both ATP and Mg2 was sufficient to initiate the PKC
phosphorylation reaction affording a peak in the MS
spectrum corresponding to the phosphorylated peptide
(Table 1). Many enzymes require both Mg2 and ATP
for their activity because the true substrate for enzymes
is not ATP4–, but an ATP-Mg2– complex [26, 27]. More-
over, the addition of Ca2 and/or PS in the presence of
ATP and Mg2 had no effect on the phosphorylation
reaction (data not shown). However, the addition of
DAG in the presence of ATP and Mg2 accelerated the
reaction. The obtained peak intensity was higher (about
two times) than that observed for Ca2 and/or PS
addition (Table 1). These results are closely related to
the DAG function for the PKC phosphorylation reac-
tion. DAG is a membrane lipid and its binding to the C1
domain of PKC activates PKC. However, the PKC
that exists in the cytosol is inactive [11–13]. In the
present study, the total cell lysate (membrane and
cytosol fractions) was used for the phosphorylation
reaction of PKC. Therefore, the addition of DAG to
these lysate samples led to activation of the PKC
present in the cytosol, resulting in an increase in the
phosphorylation ratio.
horylated peptides
Intensity (%) (n  3)
itrate With diammonium citrate
ted peptide Peptide Phosphorylated peptide
3.8 100 26.7  5.7
4.9 100 55.3  10
2.1 100 82.4  2.1
2.5 100 60.3  6.8
2.7 100 48.2  5.8hosp
um c
ryla
0.3 
9.3 
6.7 
5.3 
6.1 2.1 100 38.7  5.1
1929J Am Soc Mass Spectrom 2007, 18, 1925–1931 ADDITION OF DIAMMONIUM CITRATE TO CHCA MATRIXSince c-Src had two domains, one for substrate
binding and the other for binding the ATP-Mg2- com-
plex [15–17], phosphorylation peaks were also found on
addition of ATP and Mg2 (data not shown). These
results mean that ATP can be lost easily during lysate
preparation.
Addition Effect of Diammonium Citrate to Matrix
To identify changes in the peak intensity with varying
peptide or phosphorylated peptide concentration, we
synthesized two peptides, FKKQGSFAKKK and the
phosphorylated peptide (FKKQGphosphoSFAKKK) con-
taining phosphorylated Ser instead of the serine resi-
due. Two peptide solutions were mixed in a ratio of 1:1
(vol/vol) at concentrations of 7.5, 15, 30, 60, 120, and
240 M, then combined with CHCA in the presence or
absence of diammonium citrate, and finally analyzed by
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Figure 2. Typical MALDI-TOF mass spectra ob
with melanoma (a) and (b); normal skin tissue l
(c) diammonium citrate.MALDI-TOF mass spectrometry. In the absence ofdiammonium citrate, the intensity (about 76% of the
non-phosphorylated peptide peak intensity) of the
phosphorylated peptide was similar to that in the range
of 30 to 120 M. However, decreases in the intensity of
the phosphorylated peptide by 15% and 7% were ob-
served for peptide solution concentrations of 7.5 and 15
M, respectively, when compared with that in the
range of 30 to 120 M. In the presence of diammonium
citrate (5 mg/mL), the largest peak intensity (80% of
the non-phosphorylated peak) of the phosphorylated
peptide was obtained from a peptide solution concen-
tration of 30 M, and then the peak intensity decreased
gradually with an increase in the peptide concentration.
On the other hand, the intensity at 7.5 and 15 M
averaged 27% and 55%, respectively (Table 2).
Moreover, we examined whether there is a change in
the phosphorylation ratio by the CHCA matrix, pre-
pared with and without diammonium citrate, after the
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ysatephosphorylation reaction of peptide substrates (15, 30,
repar
1930 KANG ET AL. J Am Soc Mass Spectrom 2007, 18, 1925–1931and 60 M) with the B16 cell lysate. The phosphoryla-
tion ratio in concentrations of 15, 30, and 60 M was
40.7, 39.3, and 15.9%, respectively, in the CHCA matrix
with diammonium citrate, but 51.2, 32.2, and 10.8%
without diammonium citrate, respectively. With the
addition of diammonium citrate, the ratio decreased in
concentrations of 15 (P  0.1) and 60 M (P  0.5), but
increased in 30 M (P  0.5). These results show that if
the concentration of the substrate is optimized, the
application of diammonium citrate can elevate the
detection sensitivity for phosphorylated peptides.
In addition, we examined whether the addition of
diammonium citrate to the CHCA matrix affects the
detection of the phosphorylated peptide using tissue
lysate. The addition of diammonium citrate to CHCA
showed an enhanced ionization of the phosphorylated
peptide, and this peak intensity was greater than that
obtained for CHCA only (Figure 2a–d). Specifically, the
addition of diammonium citrate to the CHCA matrix
elevated the detection sensitivity for the small peaks
associated with the phosphorylated peptide, helping to
distinguish them from the background noise (Figure 2c
and d). In addition, the phosphorylation of a c-Src
substrate for brain tissue lysate samples produced a
higher peak in the presence of diammonium citrate,
compared when no diammonium citrate was present in
the CHCA matrix (Figure 3). Both Figures 2 and 3
showed a high signal-to-noise ratio in the presence of
diammonium citrate, leading to an elevated detection
sensitivity for phosphorylated peptides. These results
suggest that the addition of diammonium citrate to the
CHCA matrix may be of benefit for the detection of
small phosphorylation peaks if the peptide concentra-
tion is sufficient.
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Figure 3. Typical MALDI-TOF mass spectra o
with brain tissue lysate using a CHCA matrix pThe identification of phosphorylated peptides orproteins for certain protein kinases is essential for the
characterization of, or search for, substrate proteins for
enzymes. The identification process will also be impor-
tant in explorations for new drugs [12, 13, 18, 19]. The
application of diammonium citrate to MALDI-TOF
mass spectrometry technique may be useful for identi-
fying phosphorylated peptides or proteins for certain
protein kinases.
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